Atovaquone/Proguanil Hydrochloride Mylan

Atovaquone/Proguanil Hydrochloride Mylan is a combination medication used to prevent and treat malaria. This oral medication is effective in managing malaria caused by Plasmodium falciparum.

Atovaquone/Proguanil Hydrochloride Mylan is primarily used for the prevention and treatment of malaria. It is effective against Plasmodium falciparum, a common malaria-causing parasite. This medication is often prescribed for travelers to areas where malaria is prevalent. It works by interfering with the growth of the parasite in the red blood cells.

Common effects of Atovaquone/Proguanil Hydrochloride Mylan may include nausea, vomiting, diarrhea, and headache. Some users may experience abdominal pain or loss of appetite. These effects are generally mild and temporary, but if they persist or worsen, it is advisable to consult a healthcare professional.

Atovaquone/Proguanil Hydrochloride Mylan should be used with caution in individuals with severe kidney or liver disease. It is important to follow the prescribed dosage and complete the full course of treatment. This medication should be stored at room temperature away from moisture and heat.

Atovaquone/Proguanil Hydrochloride Mylan may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. Alcohol consumption should be avoided as it may increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.